Stockreport

Boehringer-Zealand drug leads to 16.6% weight loss in late-stage trial [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF late-stage trial, as the unlisted German drugmaker seeks to catch ?up with obesity drug pioneers Eli Lilly and Novo Nordisk. The Phase III trial showed patients treate [Read more]